Cystic fibrosis charity shifts research focus

The Cystic Fibrosis Trust has outlined its ambitions to fund more collaborative and multidisciplinary research in its first-ever research strategy.

Half of the trust’s annual budget is spent on research—a figure between £3 million and £4m. Since 2001, roughly three-quarters of this has gone to the UK Cystic Fibrosis Gene Therapy Consortium, run by the Universities of Edinburgh and Oxford, and Imperial College London.

The consortium is now conducting phase IIB clinical trials of one of its treatments, and the trust is looking to support a wider range of research.